Issue 83, 2022

A protein-conjugated photosensitizer with mitochondrial targeting for enhanced photodynamic therapy

Abstract

A protein-conjugated photosensitizer with mitochondrial targeting ability was synthesized to enhance the therapeutic effects of PDT. The ROS produced by the photosensitizer under laser irradiation could effectively destroy key intracellular proteins and disrupt mitochondrial redox homeostasis, thereby causing mitochondrial dysfunction and irreversible cell death.

Graphical abstract: A protein-conjugated photosensitizer with mitochondrial targeting for enhanced photodynamic therapy

Supplementary files

Article information

Article type
Communication
Submitted
03 Jun 2022
Accepted
21 Sep 2022
First published
22 Sep 2022

Chem. Commun., 2022,58, 11729-11732

A protein-conjugated photosensitizer with mitochondrial targeting for enhanced photodynamic therapy

M. Shi, W. Pan, P. Gao, Y. Chen, K. Wang, N. Li and B. Tang, Chem. Commun., 2022, 58, 11729 DOI: 10.1039/D2CC03141H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements